Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

Shiraz E-Medical Journal

homeHome
play_arrowCurrent IssuelistAll Issuesformat_indent_increaseIn Presscheck_circleAccepted ManuscriptssearchSearch
settingsInstructions
infoJournal InformationgroupsBoards and CommitteesshareIndexing and Listing Sourcesshow_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementassignment_indReviewer and AE Registration FormcampaignAnnouncementemailSupportphoneContact Us
format_list_bulletedAPC
Authors GuideSubmit Manuscript

Outlines

https://doi.org/10.5812/semj-146903

Artificial Intelligence in Diabetes Management: Revolutionizing the Diagnosis of Diabetes Mellitus; a Literature Review

Author(s):
Alireza KeshtkarAlireza Keshtkar1, Nazanin AyarehNazanin AyarehNazanin Ayareh ORCID2,*, Farnaz AtighiFarnaz AtighiFarnaz Atighi ORCID2, Reza HamidiReza Hamidi2, Parsa YazdanpanahiParsa YazdanpanahiParsa Yazdanpanahi ORCID2, Alireza KarimiAlireza KarimiAlireza Karimi ORCID2, Arzhang NaseriArzhang NaseriArzhang Naseri ORCID3, Fatemeh HosseiniFatemeh Hosseini2, Mohammad Hossein DabbaghmaneshMohammad Hossein DabbaghmaneshMohammad Hossein Dabbaghmanesh ORCID3, 4,**
1Research Center of Noncommunicable Disease, Jahrom University of Medical Sciences, Jahrom, Iran
2Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
3Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
4Shiraz University of Medical Sciences, Shiraz, Iran.
Corresponding Authors:
Shiraz E-Medical Journal:Vol. 25, issue 7; e146903
Published online:Jul 23, 2024
Article type:Review Article
Received:Mar 12, 2024
Accepted:May 11, 2024
How to Cite:Keshtkar A, Ayareh N, Atighi F, Hamidi R, Yazdanpanahi P, et al. Artificial Intelligence in Diabetes Management: Revolutionizing the Diagnosis of Diabetes Mellitus; a Literature Review. Shiraz E-Med J. 2024;25(7):e146903. doi: https://doi.org/10.5812/semj-146903

Abstract

Context:

The diagnostic methods for diabetes mellitus (DM), a chronic metabolic disorder characterized by elevated blood sugar levels, are rapidly evolving thanks to artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL). This review explores the applications of AI in risk assessment and diagnosing different types of diabetes.

Evidence Acquisition:

The review highlights the effectiveness of various ML models, including support vector machines (SVMs), random forests (RFs), and DL techniques like convolutional neural networks (CNNs), in achieving high diagnostic accuracy. Challenges include limited data availability, interpretability of complex models, and the need for standardized performance metrics.

Results:

Machine learning methods like SVMs and RFs are highly effective at diagnosing different types of diabetes, and DL techniques like CNNs also show great promise.

Conclusions:

Overall, AI has immense potential to revolutionize diabetes diagnosis by facilitating risk assessment and early detection, improving treatment efficacy, and preventing severe complications.

Keywords
Diabetes Mellitus
Diagnosis
Machine Learning (ML)
Deep Learning (DL)
Artificial Intelligence (AI)

1. Background

Diabetes mellitus (DM) encompasses a group of chronic metabolic disorders characterized by sustained elevations in blood sugar (glucose) levels (1). Hyperglycemia, a hallmark of diabetes, leads to severe complications such as retinopathy, heart disease, kidney failure, and mucormycosis infections. In 2017, 425 million people had diabetes, resulting in 4 million deaths. These numbers are projected to rise, burdening healthcare systems (2-4).
There are three main classifications of DM: Type 1 diabetes (T1DM), type 2 diabetes (T2DM), and gestational diabetes (GDM) (5). Type 2 diabetes, the most prevalent form, is characterized by progressive insulin resistance and declining insulin secretory capacity. Gestational diabetes is a temporary condition during pregnancy that resolves after childbirth (1, 6). Effective diabetes management across all classifications depends on timely diagnosis (7).
Artificial intelligence (AI) is a rapidly evolving field with expanding applications in prediction, risk assessment, and early diagnosis of diabetes. Machine learning (ML) algorithms hold immense potential to revolutionize clinical practice by automating diagnoses (8). Diabetes care is at the forefront of adapting and integrating ML technology, offering promising potential for improving patient outcomes (8, 9).

1.1. Artificial Intelligence in Medicine

This paper delves into the use of AI in medicine. Artificial intelligence, a discipline within computer science, develops systems and methods for data analysis across diverse applications (10, 11). This section provides a brief review of several popular computational intelligence paradigms.
Machine learning is a core AI technique for pattern recognition within specific datasets. Through data fitting, machines can "learn" and apply this knowledge to similar future scenarios (12).

1.2. Applications of Machine Learning in Medicine

Diagnosis of diabetes greatly benefits from ML techniques in medicine. Machine learning aids in identifying high-risk individuals for specific diseases. Recent successes include utilizing ML algorithms to predict diabetes at an early stage using electronic health record data (13).
Machine learning encompasses two prominent forms: Artificial neural networks (ANNs) and deep learning (DL), with the latter being more complex. Inspired by the biological brain's structure and function, ANNs consist of interconnected nodes (neurons) that process information using mathematical functions (14).
Deep learning employs ANNs to model and analyze data. It uses layered nonlinear units to learn intricate patterns from large datasets, eliminating the need for manual feature engineering. Subcategories include convolutional neural networks (CNNs), recurrent neural networks (RNNs), stacked autoencoders (SAEs), and deep belief networks (DBNs) (15). Deep learning approaches like CNNs have been successful in tasks such as predicting diabetic retinopathy from retinal scans, highlighting their potential to improve early diabetes diagnosis and care (16, 17). Natural language processing (NLP) enables computers to understand and generate human language. It is used in tasks such as speech recognition, language translation, sentiment analysis, and text summarization. Subcategories include syntax analysis, semantics analysis, named entity identification, machine translation, and question answering (18, 19). Natural language processing models, like ChatGPT, find diverse applications in medical sciences, covering diagnostics, research, treatment, decision-making, and scholarly writing. However, the reliability of ChatGPT in scientific writing is questionable due to its potential for generating unreliable references (20, 21).

1.3. Artificial Intelligence in Type 2 Diabetes Mellitus

Artificial intelligence has significant potential to enhance healthcare for diabetic patients. Machine learning, particularly in the context of T2DM, aids in early diagnosis, assisting both doctors and patients (22). Researchers have extensively explored various ML models to identify risk factors associated with the disease (23, 24).

2. Objectives

This study reviews the effectiveness of various ML models in achieving improved diagnostic accuracy and risk factor identification. As research in this field continues to evolve, we can expect even more sophisticated ML approaches to emerge, paving the way for a future of preventative T2DM care.

3. Methods

A literature review was conducted using the PubMed, Scopus, and Web of Science databases. These reliable tools were chosen due to their extensive healthcare-related content. The review focused on English-language documents published between 2019 and 2024. To curate relevant studies, we employed a comprehensive search query comprising the following keywords:
Diabetes, Diabetes mellitus, DM, Diabetic, T2DM, T1DM, Artificial intelligence, AI, Deep learning, Machine learning, Computational intelligence, Data mining, Pattern recognition, Neural network, Reinforcement learning, Diagnosis*, Identify, Detect*.
The inclusion and exclusion criteria for selecting the appropriate papers are mentioned in Table 1.
Table 1.The Inclusion and Exclusion Criteria Used for Screening the Gathered Articles
Inclusion CriteriaExclusion Criteria
Last 5 years Duplicate articles
English articles Studies with incomplete data or unannounced outcome
Research done on diabetes mellitus patientsUnrelated study designs including literature
Cohort or case-control studies Review, case reports, book chapters
Related to the applications of artificial intelligence in the diagnosis of diabetes mellitus in patientsStudies with no access to their full text or abstract

3.1. Performance Metrics

Algorithm transparency and clinical assessment are crucial for vulnerable populations. Reported performance metrics varied across studies, with accuracy, F1 score, and AUC commonly employed for model evaluation.
Accuracy measures the proportion of correct predictions by a model. However, it can be misleading for imbalanced datasets, where predicting all observations as the majority class can inflate the accuracy score (25).
The F1 score is a machine-learning metric that combines precision and recall. It assesses a model’s accuracy by considering its class-wise performance rather than its overall performance. Precision measures how many of the predicted positive instances were actually positive. Recall measures how many of the actual positive instances were correctly predicted. The F1 score is the harmonic mean of precision and recall, ranging from 0 to 1, with a score of 1 representing the best possible performance (26).
Area under the curve (AUC) assesses model performance across various thresholds. It is applicable to classifiers providing confidence scores or probabilities. A perfect model achieves an AUC of 1, while a model with no discriminatory power results in an AUC of 0.5 (26).

4. Results

4.1. Analysis of Artificial Intelligence Models for Diagnosis

Among the 68 articles on AI-based diagnosis, 32 lacked full-text access and were excluded. The remaining 36 studies explored a variety of ML and DL models. Figure 1 highlights the growing interest in AI for diabetes diagnosis.
Number of published articles in each year till February 2024
Figure 1.

Number of published articles in each year till February 2024

From these 68 articles, only 36 had access to full text, and 32 were discarded from this study.
Table 2 presents the details of the included studies.
Table 2.Delves Deep into the Effectiveness of Various Machine Learning (ML) and Deep Learning (DL) Algorithms for Diagnosing Diabetes Mellitus
AuthorPublication YearSample SizeSelected FeaturesAI ModelModel AlgorithmF1scoreAUCAccuracy
Albahli, S. (27)2020253, 395FBS, HbA1c, gamma-GTP, BMI, TG, age, uric acid, sex, physical activity, drinking, smoking, and family historyMLK-mean clustering + LRUnmentionedUnmentioned0.9753
Eyasu, K. et al. (28)202012UnmentionedNLP (Data mining)J480.95Unmentioned0.9515
PART0.944Unmentioned0.9451
JRip0.947Unmentioned0.9473
Islam, M. et al. (29)20201570Type of place, electricity, wealth index, age, education, working status, smoking, arm circumference, taking medicine, weight, and BMIMLSVMUnmentioned0.6620.929
RFUnmentioned0.5930.923
Linear discriminant analysisUnmentioned0.660.926
LRUnmentioned0.6820.925
NNUnmentioned0.680.928
Bagged classification and regression tree (Bagged CART)Unmentioned0.60.943
Kopitar, L. et al. (30)20203723A set of 58 variables that were not mentioned specifically. Generally, it includes an INDRISC (FR) questionnaire, physical activity (at least 30 min during the day), fruit and vegetable consumption, a history of antihypertensive drug treatment, a history of high blood glucose levels, and a family history of diabetes.MLLinear regressionUnmentioned0.854Unmentioned
Regularised generalised linear model (Glmnet)Unmentioned0.859Unmentioned
RFUnmentioned0.852Unmentioned
eXtreme gradient boosting (XGBoost)Unmentioned0.844Unmentioned
Light gradient boosting machine (lightGBM)Unmentioned0.847Unmentioned
Li, Y. et al. (31)2020147UnmentionedMLSVMUnmentionedUnmentioned0.9722
Liu, Y. (32)2020650 groupsFBS, 2-hpp, clinical symptoms: Thirst, dry mouth, excessive drinking, polyphagia, polyuria, weight loss, family history, smoking and drinkingMLMATLAB Neural NetworkUnmentionedUnmentioned0.92
Al Masud, F. et al. (33)2021306Age, area of residence, standard growth rate, HbA1c, hypoglycemia, adequate nutrition, autoantibodies, sex, and family history of type 1 and 2 diabetesMLRanker analysis, data miningUnmentionedUnmentionedUnmentioned
Deepa, S.N and Banerjee, Abhik (34)2021900Images of the tongueMLCNN + SVM0.9831Unmentioned0.9782
Dietz, B. et al. (35)20212371T1-weighted whole-body MRI, sex, age, BMI, insulin sensitivity, and HbA1cDLDense CNNUnmentioned0.87Unmentioned
Islam, M. et al. (36)2021492Retinal imagesDLCNNUnmentioned0.662Unmentioned
Lee, W.S. et al. (37)20211000Synthetic glucose profilesMLShallow neural networkUnmentionedUnmentioned0.873
DLMultilayer perceptron (MLP)UnmentionedUnmentioned0.9
CNNUnmentionedUnmentioned0.865
RNNUnmentionedUnmentioned0.0866
Samreen, S. (38)2021520Age, sex, polyuria, polydipsia, sudden weight loss, weakness, polyphagia, genital thrush, visual blurring, itching, irritability, delayed healing, partial paresis, muscle stiffness, alopecia, and obesityMLNBUnmentioned0.950.8961
KNNUnmentioned0.980.9487
LRUnmentioned0.970.9269
SVMUnmentioned0.990.9833
DTUnmentioned0.960.9685
RFUnmentioned0.990.9833
Adaboost(AB)Unmentioned0.980.9641
Gradient boost (GB)Unmentioned0.990.9717
Srivastava A.K, et al. (39)2021Unmentioned. Pima Indian diabetes datasetUnmentionedMLDNN0.89310.92360.9474
Xiang, Y. et al. (40)2021165Fundus images, tongue appearance, and pulse characteristicsMLRF0.76Unmentioned0.85
Zhang,k. et al. (41)202157672 cases and 115344 retinal imagesFundus images, age, sex, height, weight, BMI, and blood pressureDLRFUnmentionedUnmentioned0.93
MLCNNUnmentionedUnmentioned0.861
Alshari, H. and Odabas, A. (42)202214682Physical activity, dietary, smoking features, alcohol consumption, hypertension, age, gender, race, marital status, education level, annual family income, and the ratio of family income to poverty guidelinesMLXGBoost0.7480.8420.846
LightGBM0.7490.8430.846
CatBoost0.7370.8360.836
Neural networks0.7210.8210.829
Anaya-Isaza, A. and Zequera-Diaz, M (43)2022167Foot thermographyDLCNN0.8583Unmentioned0.8278
Balasubramaniyan, S. et al. (44)20222675Tongue images: Tongue shape and color, fissure identification, fur color and fur thickness, tooth markings, and red dotDLCNN0.99Unmentioned0.984
Ellouze, A. et al. (45)2022768Pregnancy, plasma glucose concentration, diastolic blood pressure, triceps skinfold thickness, insulin, mass, pedigree of diabetes, and ageMLKNN0.770.760.77
SVM0.80.870.8
DT0.760.790.75
DLRNN0.930.950.93
CNN0.90.920.9
Long short-term memory (LSTM)0.970.990.97
Long short-term memory (LSTM)0.950.970.95
Fufurin, I. et al. (46)20221200 infrared exhaled breath spectra from 120 volunteersExhaled breath samples and using IR breath spectraDLCNNUnmentioned0.990.997
Hossain, E. et al. (47)2022UnmentionedNumber of pregnancies, BMI, insulin levels, age, glucose, skin fold thickness, blood pressure, and diabetes pedigree functionMLKNN & LightGBM0.840.9360.891
Rabie, O. et al. (48)2022829Age, BMI, glucose, the number of pregnancies, blood pressure, skin foldthickness, two-hour insulin, and pedigree diabetes functionDLDNN0.92Unmentioned0.9307
Ullah, Z. et al. (49)2022253680Comprised a total of 22 features: Blood pressure, high cholesterol, BMI, smoking, Stroke, heart diseases, fruits, veggies, heavy alcohol consumption, any health care, sex, age, etc.MLNearest neighbor (SMOTE-ENN)0.980.980.9838
Zee, B. et al. (50)20222221Retinal imaging with a non-mydriatic fundus cameraMLSVMUnmentioned0.993Unmentioned
Garcia-Dominguez, A et al. (51)20231019Diastolic blood pressure, systolic blood pressure, glucose, height, LDL, waist circumference, TG, education, insulin, gender, cholesterol, and ageMLNeural network0.860.9340.86
Iparraguirre-Villanueva, O.et al. (52)2023768Number of pregnancies, glucose level, diastolic blood pressure, thickness of skin folds, insulin levels, BMI, genetic history of diabetes, and ageMLNearest neighbor(NN)Unmentioned0.6670.753
Naïve Bayes(NB)Unmentioned0.6770.461
Decision tree(DT)Unmentioned0.6020.708
LRUnmentioned0.5550.698
SVMUnmentioned0.560.67
Salem Alzboon, M. et al. (53)2023768Data set of 8 demographics and clinical details: Age, gender, number of pregnancie, BMI, blood pressure, skin thickness, insulin level, and glucose concentrationMLLR0.6130.828Unmentioned
DT0.5670.665Unmentioned
RF0.5760.811Unmentioned
KNN0.560.776Unmentioned
NB0.640.808Unmentioned
SVM0.5830.822Unmentioned
GB0.5280.636Unmentioned
Neural network0.610.825Unmentioned
Deepa,K. and Ranjeeth Kumar, C .(54)2023UnmentionedUnmentionedMLDTUnmentionedUnmentioned0.77
KNNUnmentionedUnmentioned0.773
LRUnmentionedUnmentioned0.793
Ensemble methodUnmentionedUnmentioned0.806
Duc, L. et al. (55)2023UnmentionedUnmentionedMLSVM + ANNUnmentioned0.960.938
Nguyen et al. (56)20232153Gender, age, MI, waist circumference, hip circumference, systolic blood pressure, diastolic blood pressure, FBS, 2-hPP, total cholesterol, TG, HDL and insulinMLRF0.940.940.85
Nilashi, M. et al. (57)2023768Number of pregnancy, 2-hPP, diastolic blood pressure, triceps skin fold thickness, 2 hours serum insulin, BMI, diabetes pedigree function, and ageDLDBNUnmentionedUnmentioned0.9832
Önal et al. (58)202368Full irtis images, the iris segmentation from raw images, the segmentation of the pancreatic region in the iridology chartDLCNN0.8333Unmentioned0.8
Shaukat, Z.et al. (59)2023768Number of pregnancies, plasma glucose concentration,diastolic blood pressure,triceps skinfold thickness,2-hour serum insulin,BMI,diabetes pedigree function, and ageMLDT0.720.8390.7186
KNN0.720.6970.723
RF0.780.8320.7879
LRUnmentioned0.8480.7966
SVM0.790.7230.7922
Zhang, J. et al. (60)2023820A set of nine clinical feature: Admission glucose, BMI > 28, cardiovascular disease, age, NAFLD, ALT, HDL-C < 1.03, UA, and smokingMLLR0.3570.819Unmentioned

z Abbreviations: AUC, area under curve; KNN, K nearest number; SVM, support vector machines; RF, random forest; CART, classification and regression tree; XGBoost, extreme gradient boosting; CNN, convolutional neural network; MLP, multilayer perceptron; DT, decision trees; AB, adaboost; DNN, deep neural network; GB, gradient boost; RNN, recurrent neural network; LSTM, long short term memory; SMOTE-ENN, synthetic minority over-sampling technique–edited nearest neighbor; NB, naive bayes; ANN, artificial neural network; ML, machine learning;DL, deep learning; LR, logistic regression; AI, artificial intelligence .

4.2. Machine Learning Techniques

4.2.1. Support Vector Machines (SVMs)

support vector machine is an ML method primarily used to classify data by finding a maximum decision boundary to separate data from different classes. The strengths of SVMs are their ability to handle high-dimensional features and various types of unstructured data, such as text and images. However, SVMs struggle when classes overlap significantly and when high dimensionality leads to overfitting, resulting in poor generalization to new data (61).
SVM performance is promising, with studies achieving high accuracies. For instance, Wang et al. employed SVMs with radial basis function (RBF) kernels and achieved accuracies exceeding 90%, highlighting the importance of proper kernel selection in model performance (62). Similarly, Ellouze et al. reported 80% accuracy, while Zee achieved an exceptional 99.3% accuracy by using internal and external validation, demonstrating potential for practical applicability (45, 50).
However, Iparraguirre-Villanueva et al. observed a lower accuracy of 56%, highlighting potential limitations with specific datasets or parameter tuning (52). Further investigation into SVM kernel selection, optimization techniques, and generalizability using larger and balanced datasets alongside adequate validation could be beneficial (Appendix 1).

4.2.2. Random Forests (RFs)

Random forest is an ML method that combines multiple decision tree outcomes to report the best single result. Similar to SVM, RF can be used in classification and regression tasks and can handle high-dimensional spaces. However, the complexity of RFs in generating explanations decreases their interpretability (63). These models consistently demonstrate strong performance. Islam et al. achieved an outstanding F1 score of 0.99, signifying excellent classification ability (36). Similarly, Nguyen et al. reported an accuracy of 85% and an AUC of 0.94, showcasing RFs' capability for accurate diabetic/non-diabetic case identification (56). Studies by Shaukat et al. (accuracy: 78.79%) and Xiang et al. (accuracy: 85%) suggest that RFs might benefit from dataset-specific optimization for peak performance (40, 59). Although increasing the number and depth of trees by using larger datasets can improve the algorithm's robustness, it should be considered that it leads to longer training times and requires more memory than other algorithms (63). See Appendix 2 for detailed results.

4.2.3. K-Nearest Neighbors (KNNs)

This ML method finds the most probable prediction by grouping the inputs. The inputs that have the least distance on the chart are gathered in a group. The value of the group is determined by the mean or the majority vote of each group participant. . K-nearest neighbors's simplicity and ease of implementation make it a good choice for real-world applications, such as in the medical field, where understanding the decision-making process is essential for trusting the model outcomes. However, its simplicity struggles to handle large, imbalanced, and complex data (45).
K-nearest neighbor results show considerable variation. Samreen reported a high accuracy of 94.87%, and Ellouze et al. achieved a moderate accuracy of 77% (38, 45). Conversely, Iparraguirre-Villanueva et al. observed a lower accuracy of 66.7% (52) (Figure 2). This variability emphasizes the sensitivity of KNNs to data characteristics and parameter selection. Further research could explore techniques for optimal K-value selection and distance metric choice for enhanced performance. See Appendix 3 for detailed results.
Machine learning vs deep learning: A comparison of performance metrics on research papers
Figure 2.

Machine learning vs deep learning: A comparison of performance metrics on research papers

4.2.4. Logistic Regression

Logistic regression (LR) is a discriminative model for binary classification that models the probability of an input belonging to a class using a logistic function. It employs coefficients to predict probabilities. Logistic regression is a straightforward algorithm, making it accessible to apply, train, and interpret. However, it assumes linear relationships between variables and log odds of outcomes, which can reduce its flexibility and suitability for real-world data (57, 64).
Logistic regression yielded mixed results. Islam et al. achieved an accuracy of 66.2% using LR, whereas Salem Alzboon et al. reported an accuracy of 61.3% and an AUC of 0.828 (29, 53). However, Villanueva et al. documented a lower accuracy of 55.5% for LR (52). These findings suggest limitations of LR in specific scenarios, potentially due to dataset linearity assumptions. Exploring regularization techniques and feature engineering could be beneficial for improving LR's effectiveness in diagnosing diabetes. See Appendix 4 for detailed results.

4.2.5. Neural Networks (NNs)

Neural networks predict the outcome of interest by passing input information through layers of interconnected neurons with learnable weights. Each neuron applies an activation function to the weighted sum of inputs, enabling complex nonlinear mappings. Through forward and backward propagation, NNs learn to minimize a loss function, adjusting weights to generate accurate predictions (15).
The performance of NNs varied considerably. Liu achieved an accuracy of 92% using a MATLAB Neural Network, while Salem Alzboon et al. reported an accuracy of 61% for a general neural network (32, 53). Garcia-Dominguez et al. documented a moderate accuracy of 86% for a neural network (51). These variations highlight the dependence of NN performance on factors like network architecture, training data size and quality, and hyperparameter tuning. Studies by Srivastava et al. (accuracy: 89.31%) and Rabie et al. (accuracy: 92%) further showcase the potential of NNs with careful optimization (39, 48). See Appendix 5 for detailed results.

4.3. Deep Learning Techniques

Deep learning approaches, including CNNs and RNNs, demonstrated promising results in some studies. Their ability to automatically learn from data without manual feature extraction and labeling makes these techniques suitable for tasks where defining features is challenging, such as medical image processing. However, clinical applicability remains difficult due to the complexity of interpreting and identifying errors or biases in the models (16, 17).
Anaya-Isaza and Zequera-Diaz achieved an accuracy of 85.83% using CNNs, while Ellouze et al. reported an accuracy of 97% for LSTMs (a type of RNN) (43, 45). Conversely, Önal et al. documented a lower accuracy of 83.33% for a CNN, suggesting that DL techniques might require substantial data for optimal performance (58). Further research into data augmentation techniques and transfer learning could be beneficial for improving the generalizability of DL models in diabetes diagnosis. See Appendix 6 for detailed results.

4.4. Ensemble Methods

A limited number of studies explored ensemble methods. Duc et al. combined SVM and an artificial neural network, achieving an accuracy of 93.8% (55). Deepa and Ranjeeth Kumar reported an accuracy of 80.6% for an ensemble method, indicating their potential effectiveness in diabetes diagnosis (54). Further investigation into ensemble methods that combine the strengths of different algorithms is warranted.
Figure 3 presents three scatter plots that analyze the performance of various AI models designed to diagnose DM at an early stage. These plots utilize three key metrics: Area Under the Curve, F1 score, and accuracy. The upper left scatter plot depicts the relationship between F1 score and AUC. Here, we observe that all the models achieve relatively good performance, with F1 and AUC scores consistently exceeding 0.65. The upper right scatter plot focuses on the models' accuracy compared to their F1 score. Interestingly, most data points reside above the diagonal line, signifying that overall accuracy tends to be higher than the F1 score. This implies that the models excel at correctly classifying the majority of cases but might struggle with specific subgroups within the data. For example, a model might be adept at identifying healthy individuals yet less proficient at distinguishing between pre-diabetic and diabetic patients. The lower scatter plot explores the models' performance using both AUC and accuracy. This plot reveals a positive finding: A cluster of data points occupies the upper right quadrant. This positioning signifies that a substantial portion of the models exhibit both high AUC and high accuracy, effectively differentiating between individuals with and without DM. Notably, a few models stand out in the upper right corner, achieving exceptionally high values for both metrics.
Scatter plots of performance metrics for machine learning and deep learning models in early diabetes detection
Figure 3.

Scatter plots of performance metrics for machine learning and deep learning models in early diabetes detection

Figure 4 presents a comparative analysis of the algorithms implemented within various ML models. The evaluation emphasizes the F1 score and AUC as the primary performance metrics. This choice is driven by the critical need to accurately identify pre-diabetic and diabetic individuals within a population. Notably, the results demonstrate that many models achieve F1 scores and AUCs exceeding 80%. This high performance suggests significant promise for the real-world application of these AI models in clinical settings. Their ability to accurately identify pre-diabetic and diabetic patients can significantly improve preventative measures and patient outcomes.
F1 score, this line chart compares the F1 score of different machine learning models.
Figure 4.

F1 score, this line chart compares the F1 score of different machine learning models.

The F1 score is a metric that balances precision and recall. Area Under the Curve represents the probability that the model will rank a positive instance higher than a negative instance. Accuracy is the proportion of correct predictions made by the model.
Figure 2 shows a grouped bar chart comparing the performance metrics of various research papers. Each bar group represents a paper by a specific author, and the bars within each group represent performance on three metrics: F1 score, accuracy, and AUC. These metrics are color-coded for easy differentiation.

5. Discussion

In summary, AI, particularly ML and DL, can revolutionize diabetes management. Machine learning methods (SVMs, RFs) excel in diagnosis, while CNNs show promise.
Multiple publications have addressed the topic of our review, exploring AI applications in DM diagnosis to various extents. A significant number of them aimed to review studies with ML algorithms to screen complications of DM, such as cardiovascular complications and diabetic retinopathy (65). As mentioned earlier, DL models, especially CNNs, are widely used for medical imaging recognition and have shown promising outcomes. Most of these studies used CNN-based models trained on multi-center medical imaging datasets or public datasets, such as the Indian Diabetic Retinopathy Image Dataset (66). Other papers have investigated the potential of diabetes prediction and early detection to initiate timely intervention and improve outcomes by utilizing ML-based models. Since there is a broad spectrum of risk factors, symptoms, and signs for this disorder, various features are used in each article (67). Some of these models were trained on data extracted from electronic medical records as a large, real-time clinical data source (68). Much effort has been made to identify the most weighted demographic, clinical, or laboratory features for developing a predictive model with maximum accuracy. Parameters such as blood sugar level, BMI, triglyceride level, HbA1c, and pregnancy have showcased the most predictive value (69). Our study is not limited to a particular diagnostic method, as we have compared various AI-powered advancements in the field of DM diagnosis. According to our results, the accuracy of the model increased when DL and ML techniques were used simultaneously. However, there are challenges to overcome. The lack of sufficient data, especially for specific groups or rare types of diabetes, can hinder the effective use of AI. Understanding complex AI models, particularly DL ones, is a concern for healthcare providers who need to understand why the models make certain predictions. Additionally, the lack of standard methods to measure AI performance makes it difficult to compare different studies.
To maximize the benefits of AI in diabetes care, we need to address these challenges. Gathering more data while protecting patient privacy is essential. Research on making AI models more understandable, such as using explainable AI (XAI), can help build trust and facilitate the broader adoption of AI in healthcare.

5.1. Future Research Directions and Open Challenges

Advancing AI in DM diagnosis and addressing evolving challenges requires further research in several key areas. The following research directions can help improve the efficiency and reliability of AI systems in this field.
First, developing sustainable AI models necessitates the availability of rich and high-quality data. Future studies should focus on expanding datasets to include a broader range of populations and clinical scenarios. Additionally, the collection of longitudinal data and real-world evidence can enhance the generalizability of AI algorithms in diabetes diagnosis (70).
Second, researchers should explore methods to identify and mitigate biases and errors in diabetes diagnosis algorithms. Promoting transparency in algorithm development and decision-making processes can build trust among stakeholders. Moreover, the interpretation of AI models is crucial for clinical acceptance. Future research should concentrate on developing explanatory AI techniques that provide insights into how the model makes its predictions. By improving the interpretability of the model, doctors can better understand and trust the recommendations of AI systems when diagnosing diabetes (71). Third, to facilitate the adoption of AI tools in clinical practice, future research should explore ways to seamlessly integrate these systems into existing healthcare workflows. Collaboration between AI researchers and healthcare providers can help adapt AI solutions to the specific needs and constraints of the clinical environment, ultimately improving the utility and impact of AI in diabetes diagnosis. Pursuing these lines of research can advance the field of AI in diagnosing diabetes, ultimately improving patient outcomes and healthcare (72).

Footnotes

References

  • 1.
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37 Suppl 1:S81-90. [PubMed ID: 24357215]. https://doi.org/10.2337/dc14-S081.
  • 2.
    Eftekhari MH, Akbarzadeh M, Dabbaghmanesh MH, Hassanzadeh J. The effect of calcitriol on lipid profile and oxidative stress in hyperlipidemic patients with type 2 diabetes mellitus. ARYA Atheroscler. 2014;10(2):82-8. [PubMed ID: 25161675]. [PubMed Central ID: PMC4144370].
  • 3.
    International Diabetes Federation. IDF diabetes atlas. Brussels, Belgium: International diabetes federation; 2017. Available from: https://diabetesatlas.org/upload/resources/previous/files/8/IDF_DA_8e-EN-final.pdf.
  • 4.
    Nahaei M, Motazedian G, Mohammadi AA, Davarpanah MA, Yazdanpanahi P, Ayareh N, et al. Evaluation of Clinical Manifestations, Pattern of Involvement, and Surgical Outcomes in Patients with Post Covid-19 Head and Neck Mucormycosis Infection among Patients Admitted To Namazi Hospital, Shiraz, Iran (2021-2022). World J Plast Surg. 2023;12(3):64-72. [PubMed ID: 38226199]. [PubMed Central ID: PMC10788107]. https://doi.org/10.61186/wjps.12.3.64.
  • 5.
    World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva, Switzerland: World Health Organization; 2013, [cited 2032]. Available from: https://www.who.int/publications/i/item/WHO-NMH-MND-13.2.
  • 6.
    Montazeri-Najafabady N, Dabbaghmanesh MH, Namavar Jahromi B, Chatrabnous N, Chatrsimin F. The impact of GSTM1 and GSTT1 polymorphisms on susceptibility to gestational diabetes in Iranian population. J Matern Fetal Neonatal Med. 2022;35(8):1451-6. [PubMed ID: 32345069]. https://doi.org/10.1080/14767058.2020.1757062.
  • 7.
    Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al. AACE comprehensive diabetes management algorithm 2013. Endocr Pract. 2013;19(2):327-36. [PubMed ID: 23598536]. https://doi.org/10.4158/endp.19.2.a38267720403k242.
  • 8.
    Angehrn Z, Haldna L, Zandvliet AS, Gil Berglund E, Zeeuw J, Amzal B, et al. Artificial Intelligence and Machine Learning Applied at the Point of Care. Front Pharmacol. 2020;11:759. [PubMed ID: 32625083]. [PubMed Central ID: PMC7314939]. https://doi.org/10.3389/fphar.2020.00759.
  • 9.
    Muehlematter UJ, Daniore P, Vokinger KN. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis. Lancet Digit Health. 2021;3(3):e195-203. [PubMed ID: 33478929]. https://doi.org/10.1016/S2589-7500(20)30292-2.
  • 10.
    Konar A, Jain LC. An Introduction to Computational Intelligence Paradigms. In: Jain L, Wilde P, editors. Practical Applications of Computational Intelligence Techniques. 16. Dordrecht, Netherlands: Springer Dordrecht; 2001. p. 1-64. https://doi.org/10.1007/978-94-010-0678-1_1.
  • 11.
    Engelbrecht AP. Computational Intelligence: An Introduction. Hoboken, New Jersey: John Wiley & Sons; 2007. https://doi.org/10.1002/9780470512517.
  • 12.
    Kaul V, Enslin S, Gross SA. History of artificial intelligence in medicine. Gastrointest Endosc. 2020;92(4):807-12. [PubMed ID: 32565184]. https://doi.org/10.1016/j.gie.2020.06.040.
  • 13.
    Sidey-Gibbons JAM, Sidey-Gibbons CJ. Machine learning in medicine: a practical introduction. BMC Med Res Methodol. 2019;19(1):64. [PubMed ID: 30890124]. [PubMed Central ID: PMC6425557]. https://doi.org/10.1186/s12874-019-0681-4.
  • 14.
    Shahid N, Rappon T, Berta W. Applications of artificial neural networks in health care organizational decision-making: A scoping review. PLoS One. 2019;14(2). e0212356. [PubMed ID: 30779785]. [PubMed Central ID: PMC6380578]. https://doi.org/10.1371/journal.pone.0212356.
  • 15.
    Choi RY, Coyner AS, Kalpathy-Cramer J, Chiang MF, Campbell JP. Introduction to Machine Learning, Neural Networks, and Deep Learning. Transl Vis Sci Technol. 2020;9(2):14. [PubMed ID: 32704420]. [PubMed Central ID: PMC7347027]. https://doi.org/10.1167/tvst.9.2.14.
  • 16.
    Yang S, Zhu F, Ling X, Liu Q, Zhao P. Intelligent Health Care: Applications of Deep Learning in Computational Medicine. Front Genet. 2021;12:607471. [PubMed ID: 33912213]. [PubMed Central ID: PMC8075004]. https://doi.org/10.3389/fgene.2021.607471.
  • 17.
    Esteva A, Robicquet A, Ramsundar B, Kuleshov V, DePristo M, Chou K, et al. A guide to deep learning in healthcare. Nat Med. 2019;25(1):24-9. [PubMed ID: 30617335]. https://doi.org/10.1038/s41591-018-0316-z.
  • 18.
    Eisenstein J. Introduction to natural language processing. Cambridge, Massachusetts: MIT press; 2019.
  • 19.
    Thanaki J. Python natural language processing. Birmingham, UK: Packt Publishing Ltd; 2017.
  • 20.
    SeyedAlinaghi S, Abbaspour F, Mehraeen E. The Challenges of ChatGPT in Healthcare Scientific Writing. Shiraz E-Medical Journal. 2023;25(2). https://doi.org/10.5812/semj-141861.
  • 21.
    Keshtkar A, Hayat A, Atighi F, Ayare N, Keshtkar M, Yazdanpanahi P, et al. ChatGPT's Performance on Iran's Medical Licensing Exams. Res Square. 2023;Preprint. https://doi.org/10.21203/rs.3.rs-3253417/v1.
  • 22.
    Gubbi S, Hamet P, Tremblay J, Koch CA, Hannah-Shmouni F. Artificial Intelligence and Machine Learning in Endocrinology and Metabolism: The Dawn of a New Era. Front Endocrinol (Lausanne). 2019;10:185. [PubMed ID: 30984108]. [PubMed Central ID: PMC6448412]. https://doi.org/10.3389/fendo.2019.00185.
  • 23.
    Rau HH, Hsu CY, Lin YA, Atique S, Fuad A, Wei LM, et al. Development of a web-based liver cancer prediction model for type II diabetes patients by using an artificial neural network. Comput Methods Programs Biomed. 2016;125:58-65. [PubMed ID: 26701199]. https://doi.org/10.1016/j.cmpb.2015.11.009.
  • 24.
    Muhammad LJ, Algehyne EA, Usman SS. Predictive Supervised Machine Learning Models for Diabetes Mellitus. SN Comput Sci. 2020;1(5):240. [PubMed ID: 33063051]. [PubMed Central ID: PMC7372976]. https://doi.org/10.1007/s42979-020-00250-8.
  • 25.
    Bratko I. Machine Learning: Between Accuracy and Interpretability.In: Della Riccia G, Lenz HJ, Kruse R, editors. International Centre for Mechanical Sciences. Vienna, Austria. Springer; 1997. p. 163-77.
  • 26.
    Yacouby R, Axman D. Probabilistic Extension of Precision, Recall, and F1 Score for More Thorough Evaluation of Classification Models. Proceedings of the First Workshop on Evaluation and Comparison of NLP Systems. Florida, United States. Empirical Methods in Natural Language Processing; 2020. p. 79-91.
  • 27.
    Albahli S. Type 2 Machine Learning: An Effective Hybrid Prediction Model for Early Type 2 Diabetes Detection. J Med Imaging Health Inf. 2020;10(5):1069-75. https://doi.org/10.1166/jmihi.2020.3000.
  • 28.
    Eyasu K, Jimma W, Tadesse T. Developing a Prototype Knowledge-Based System for Diagnosis and Treatment of Diabetes Using Data Mining Techniques. Ethiop J Health Sci. 2020;30(1):115-24. [PubMed ID: 32116440]. [PubMed Central ID: PMC7036459]. https://doi.org/10.4314/ejhs.v30i1.15.
  • 29.
    Islam MM, Rahman MJ, Chandra Roy D, Maniruzzaman M. Automated detection and classification of diabetes disease based on Bangladesh demographic and health survey data, 2011 using machine learning approach. Diabetes Metab Syndr. 2020;14(3):217-9. [PubMed ID: 32193086]. https://doi.org/10.1016/j.dsx.2020.03.004.
  • 30.
    Kopitar L, Kocbek P, Cilar L, Sheikh A, Stiglic G. Early detection of type 2 diabetes mellitus using machine learning-based prediction models. Sci Rep. 2020;10(1):11981. [PubMed ID: 32686721]. [PubMed Central ID: PMC7371679]. https://doi.org/10.1038/s41598-020-68771-z.
  • 31.
    Li Y, Guo L, Li L, Yang C, Guang P, Huang F, et al. Early Diagnosis of Type 2 Diabetes Based on Near-Infrared Spectroscopy Combined With Machine Learning and Aquaphotomics. Front Chem. 2020;8:580489. [PubMed ID: 33425846]. [PubMed Central ID: PMC7794015]. https://doi.org/10.3389/fchem.2020.580489.
  • 32.
    Liu Y. Artificial Intelligence-Based Neural Network for the Diagnosis of Diabetes: Model Development. JMIR Med Inform. 2020;8(5). e18682. [PubMed ID: 32459183]. [PubMed Central ID: PMC7287715]. https://doi.org/10.2196/18682.
  • 33.
    Al Masud F, Hosen MS, Ahmed A, Ibn Bashar M, Muyeed A, Jahan S, et al. Development of Score Based Smart Risk Prediction Tool for Detection of Type-1 Diabetes: A Bioinformatics and Machine Learning Approach. Biointerface Res Appl Chem. 2020;11(2):9007-16. https://doi.org/10.33263/briac112.90079016.
  • 34.
    Deepa SN, Banerjee A. Intelligent decision support model using tongue image features for healthcare monitoring of diabetes diagnosis and classification. Network Modeling Analysis Health Inf Bioinformatics. 2021;10(1). https://doi.org/10.1007/s13721-021-00319-1.
  • 35.
    Dietz B, Machann J, Agrawal V, Heni M, Schwab P, Dienes J, et al. Detection of diabetes from whole-body MRI using deep learning. JCI Insight. 2021;6(21). [PubMed ID: 34591793]. [PubMed Central ID: PMC8663560]. https://doi.org/10.1172/jci.insight.146999.
  • 36.
    Islam MT, Al-Absi HR, Ruagh EA, Alam T. DiaNet: A Deep Learning Based Architecture to Diagnose Diabetes Using Retinal Images Only. IEEE Access. 2021;9:15686-95. https://doi.org/10.1109/access.2021.3052477.
  • 37.
    Lee WS, Jo J, Song T. Machine learning for the diagnosis of early-stage diabetes using temporal glucose profiles. J Korean Physical Soc. 2021;78(5):373-8. https://doi.org/10.1007/s40042-021-00056-8.
  • 38.
    Samreen S. Memory-Efficient, Accurate and Early Diagnosis of Diabetes Through a Machine Learning Pipeline Employing Crow Search-Based Feature Engineering and a Stacking Ensemble. IEEE Access. 2021;9:134335-54. https://doi.org/10.1109/access.2021.3116383.
  • 39.
    Srivastava AK, Kumar Y, Singh PK. Artificial Bee Colony and Deep Neural Network-Based Diagnostic Model for Improving the Prediction Accuracy of Diabetes. Int J E-Health Med Commun. 2021;12(2):32-50. https://doi.org/10.4018/ijehmc.2021030102.
  • 40.
    Xiang Y, Shujin L, Hongfang C, Yinping W, Dawei Y, Zhou D, et al. Artificial Intelligence-Based Diagnosis of Diabetes Mellitus: Combining Fundus Photography with Traditional Chinese Medicine Diagnostic Methodology. Biomed Res Int. 2021;2021:5556057. [PubMed ID: 33969117]. [PubMed Central ID: PMC8081616]. https://doi.org/10.1155/2021/5556057.
  • 41.
    Zhang K, Liu X, Xu J, Yuan J, Cai W, Chen T, et al. Deep-learning models for the detection and incidence prediction of chronic kidney disease and type 2 diabetes from retinal fundus images. Nat Biomed Eng. 2021;5(6):533-45. [PubMed ID: 34131321]. https://doi.org/10.1038/s41551-021-00745-6.
  • 42.
    Alsharİ H, Odabas A. Machine Learning Model to Diagnose Diabetes Type 2 Based on Health Behavior. Gazi Univ J Sci. 2022;35(3):834-52. https://doi.org/10.35378/gujs.931760.
  • 43.
    Anaya-Isaza A, Zequera-Diaz M. Detection of Diabetes Mellitus With Deep Learning and Data Augmentation Techniques on Foot Thermography. IEEE Access. 2022;10:59564-91. https://doi.org/10.1109/access.2022.3180036.
  • 44.
    Balasubramaniyan S, Jeyakumar V, Nachimuthu DS. Panoramic tongue imaging and deep convolutional machine learning model for diabetes diagnosis in humans. Sci Rep. 2022;12(1):186. [PubMed ID: 34996986]. [PubMed Central ID: PMC8741765]. https://doi.org/10.1038/s41598-021-03879-4.
  • 45.
    Ellouze A, Kahouli O, Ksantini M, Alsaif H, Aloui A, Kahouli B. Artificial Intelligence-Based Diabetes Diagnosis with Belief Functions Theory. Symmetry. 2022;14(10):2197. https://doi.org/10.3390/sym14102197.
  • 46.
    Fufurin I, Berezhanskiy P, Golyak I, Anfimov D, Kareva E, Scherbakova A, et al. Deep Learning for Type 1 Diabetes Mellitus Diagnosis Using Infrared Quantum Cascade Laser Spectroscopy. Materials (Basel). 2022;15(9). [PubMed ID: 35591319]. [PubMed Central ID: PMC9099836]. https://doi.org/10.3390/ma15092984.
  • 47.
    Hossain E, Alshehri M, Almakdi S, Halawani H, Mizanur Rahman M, Rahman W, et al. Dm-Health App: Diabetes Diagnosis Using Machine Learning with Smartphone. Comput Mater Contin. 2022;72(1):1713-46. https://doi.org/10.32604/cmc.2022.024822.
  • 48.
    Rabie O, Alghazzawi D, Asghar J, Saddozai FK, Asghar MZ. A Decision Support System for Diagnosing Diabetes Using Deep Neural Network. Front Public Health. 2022;10:861062. [PubMed ID: 35372240]. [PubMed Central ID: PMC8970706]. https://doi.org/10.3389/fpubh.2022.861062.
  • 49.
    Ullah Z, Saleem F, Jamjoom M, Fakieh B, Kateb F, Ali AM, et al. Detecting High-Risk Factors and Early Diagnosis of Diabetes Using Machine Learning Methods. Comput Intell Neurosci. 2022;2022:2557795. [PubMed ID: 36210985]. [PubMed Central ID: PMC9536939]. https://doi.org/10.1155/2022/2557795.
  • 50.
    Zee B, Lee J, Lai M, Chee P, Rafferty J, Thomas R, et al. Digital solution for detection of undiagnosed diabetes using machine learning-based retinal image analysis. BMJ Open Diabetes Res Care. 2022;10(6). [PubMed ID: 36549873]. [PubMed Central ID: PMC9809219]. https://doi.org/10.1136/bmjdrc-2022-002914.
  • 51.
    Garcia-Dominguez A, Galvan-Tejada CE, Magallanes-Quintanar R, Gamboa-Rosales H, Curiel IG, Peralta-Romero J, et al. Diabetes Detection Models in Mexican Patients by Combining Machine Learning Algorithms and Feature Selection Techniques for Clinical and Paraclinical Attributes: A Comparative Evaluation. J Diabetes Res. 2023;2023:9713905. [PubMed ID: 37404324]. [PubMed Central ID: PMC10317588]. https://doi.org/10.1155/2023/9713905.
  • 52.
    Iparraguirre-Villanueva O, Espinola-Linares K, Flores Castaneda RO, Cabanillas-Carbonell M. Application of Machine Learning Models for Early Detection and Accurate Classification of Type 2 Diabetes. Diagnostics (Basel). 2023;13(14). [PubMed ID: 37510127]. [PubMed Central ID: PMC10378239]. https://doi.org/10.3390/diagnostics13142383.
  • 53.
    Salem Alzboon M, Subhi Al-Batah M, Alqaraleh M, Abuashour A, Hamadah Bader AF. Early Diagnosis of Diabetes: A Comparison of Machine Learning Methods. Int J Online Biomed Engin. 2023;19(15):144-65. https://doi.org/10.3991/ijoe.v19i15.42417.
  • 54.
    Deepa K, Ranjeeth Kumar C. Early diagnosis of diabetes mellitus using data mining and machine learning techniques. J Intell Fuzzy Syst. 2023;44(3):3999-4011. https://doi.org/10.3233/jifs-222574.
  • 55.
    Duc LA, Tung NT, Oanh TT, Tri NQ, Linh NT. Non-Invasive In Vivo Type 2 Diabetes Mellitus Diagnosis Using Raman Spectroscopy in Combination with Machine Learning. Mob Networks Appl. 2023. https://doi.org/10.1007/s11036-023-02184-w.
  • 56.
    Nguyen LP, Tung DD, Nguyen DT, Le HN, Tran TQ, Binh TV, et al. The Utilization of Machine Learning Algorithms for Assisting Physicians in the Diagnosis of Diabetes. Diagnostics (Basel). 2023;13(12). [PubMed ID: 37370981]. [PubMed Central ID: PMC10297119]. https://doi.org/10.3390/diagnostics13122087.
  • 57.
    Nilashi M, Abumalloh RA, Alyami S, Alghamdi A, Alrizq M. A Combined Method for Diabetes Mellitus Diagnosis Using Deep Learning, Singular Value Decomposition, and Self-Organizing Map Approaches. Diagnostics (Basel). 2023;13(10). [PubMed ID: 37238305]. [PubMed Central ID: PMC10217066]. https://doi.org/10.3390/diagnostics13101821.
  • 58.
    Önal MN, Güraksin GE, Duman R. Convolutional neural network-based diabetes diagnostic system via iridology technique. Multimed Tools Appl. 2022;82(1):173-94. https://doi.org/10.1007/s11042-022-13291-3.
  • 59.
    Shaukat Z, Zafar W, Ahmad W, Haq IU, Husnain G, Al-Adhaileh MH, et al. Revolutionizing Diabetes Diagnosis: Machine Learning Techniques Unleashed. Healthcare (Basel). 2023;11(21). [PubMed ID: 37958014]. [PubMed Central ID: PMC10648466]. https://doi.org/10.3390/healthcare11212864.
  • 60.
    Zhang J, Lv Y, Hou J, Zhang C, Yua X, Wang Y, et al. Machine learning for post-acute pancreatitis diabetes mellitus prediction and personalized treatment recommendations. Sci Rep. 2023;13(1):4857. [PubMed ID: 36964219]. [PubMed Central ID: PMC10038980]. https://doi.org/10.1038/s41598-023-31947-4.
  • 61.
    Cristianini N, Shawe-Taylor J. An introduction to support vector machines and other kernel-based learning methods. In: Shawe-Taylor J, Cristianini N, editors. Support Vector Machines Kernel-Based Learning Methods. Cambridge, England: Cambridge University Press; 2001.
  • 62.
    Wang F, Kaushal R, Khullar D. Should Health Care Demand Interpretable Artificial Intelligence or Accept "Black Box" Medicine? Ann Intern Med. 2020;172(1):59-60. [PubMed ID: 31842204]. https://doi.org/10.7326/M19-2548.
  • 63.
    Rigatti SJ. Random Forest. J Insur Med. 2017;47(1):31-9. [PubMed ID: 28836909]. https://doi.org/10.17849/insm-47-01-31-39.1.
  • 64.
    Maalouf M. Logistic regression in data analysis: an overview. Int J Data Analysis Tech Strateg. 2011;3(3):281. https://doi.org/10.1504/ijdats.2011.041335.
  • 65.
    Sambyal N, Saini P, Syal R. A Review of Statistical and Machine Learning Techniques for Microvascular Complications in Type 2 Diabetes. Curr Diabetes Rev. 2021;17(2):143-55. [PubMed ID: 32389114]. https://doi.org/10.2174/1573399816666200511003357.
  • 66.
    Chun JW, Kim HS. The Present and Future of Artificial Intelligence-Based Medical Image in Diabetes Mellitus: Focus on Analytical Methods and Limitations of Clinical Use. J Korean Med Sci. 2023;38(31). e253. [PubMed ID: 37550811]. [PubMed Central ID: PMC10412032]. https://doi.org/10.3346/jkms.2023.38.e253.
  • 67.
    Sharma T, Shah M. A comprehensive review of machine learning techniques on diabetes detection. Vis Comput Ind Biomed Art. 2021;4(1):30. [PubMed ID: 34862560]. [PubMed Central ID: PMC8642577]. https://doi.org/10.1186/s42492-021-00097-7.
  • 68.
    Kamel Rahimi A, Canfell OJ, Chan W, Sly B, Pole JD, Sullivan C, et al. Machine learning models for diabetes management in acute care using electronic medical records: A systematic review. Int J Med Inform. 2022;162:104758. [PubMed ID: 35398812]. https://doi.org/10.1016/j.ijmedinf.2022.104758.
  • 69.
    Abhari S, Niakan Kalhori SR, Ebrahimi M, Hasannejadasl H, Garavand A. Artificial Intelligence Applications in Type 2 Diabetes Mellitus Care: Focus on Machine Learning Methods. Healthc Inform Res. 2019;25(4):248-61. [PubMed ID: 31777668]. [PubMed Central ID: PMC6859270]. https://doi.org/10.4258/hir.2019.25.4.248.
  • 70.
    Sessions V, Valtorta M. The Effects of Data Quality on Machine Learning Algorithms. Carolina, USA: University of South Carolina; 2006, [cited 2023]. Available from: http://mitiq.mit.edu/ICIQ/Documents/IQ%20Conference%202006/papers/The%20Effects%20of%20Data%20Quality%20on%20Machine%20Learning%20Algorithms.pdf.
  • 71.
    von Eschenbach WJ. Transparency and the Black Box Problem: Why We Do Not Trust AI. Philosophy Technol. 2021;34(4):1607-22. https://doi.org/10.1007/s13347-021-00477-0.
  • 72.
    Chen M, Decary M. Artificial intelligence in healthcare: An essential guide for health leaders. Healthc Manage Forum. 2020;33(1):10-8. [PubMed ID: 31550922]. https://doi.org/10.1177/0840470419873123.
Import into EndNoteImport into BibTex
Indexed in
logoScopus
Crossmark
Crossmark
Checking
Share on
Comments
Number of Comments:0
Cited by
Metrics
Licensing and reuse information

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles

Related Article in PubMed

Related Article in Google Scholar

Create Citation Alert via Google Reader